Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:22:40.521Z.
Calculation as of: 2026-10-06T16:22:40.521Z.
Quote observation: 2026-10-06T16:20:45.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 26a6c2e450689c32f4e4e5954cf906f309ed45562a8b136dc87c806878a45fac
EARNINGS YIELD
N/A
Market Cap
$5.96B
Earnings Yield
3.14%
TTM Avg
2.27%
3Y Avg
2.59%
5Y Avg
2.85%
Market Cap
$5.89B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.76B
Earnings Yield
1.30%
TTM Avg
1.27%
3Y Avg
1.97%
5Y Avg
7.52%
Market Cap
$6.36B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.55B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.51B
Earnings Yield
4.14%
TTM Avg
4.26%
3Y Avg
5.01%
5Y Avg
4.12%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRAIL Inc. (GRAL) | $6.00B | N/A | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.96B | 3.14% | 2.27% | 2.59% | 2.85% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.89B | N/A | N/A | N/A | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.76B | 1.30% | 1.27% | 1.97% | 7.52% |
| CG Oncology Inc. (CGON)vs › | $5.73B | N/A | N/A | N/A | N/A |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.36B | N/A | N/A | N/A | N/A |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.55B | N/A | N/A | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.53B | N/A | 0.29% | 1.14% | 1.23% |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 4.14% | 4.26% | 5.01% | 4.12% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.52B | 2.39% | 1.42% | 1.11% | 1.29% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
